Substituted benzamide derivatives as glucokinase (GK) activators
    1.
    发明授权
    Substituted benzamide derivatives as glucokinase (GK) activators 有权
    取代的苯甲酰胺衍生物作为葡萄糖激酶(GK)激活剂

    公开(公告)号:US08835469B2

    公开(公告)日:2014-09-16

    申请号:US13387885

    申请日:2010-07-22

    摘要: The present invention relates to substituted benzamide derivatives of the Formula I and their pharmaceutically acceptable salts, pharmaceutically acceptable solvates, enantiomers, diastereomers, prodrugs, metabolites, and polymorphs and can be useful for treating disease states mediated by glucokinase. Compounds disclosed herein can be used for reducing blood glucose levels and for increasing insulin secretion for treating type II diabetes. The invention also relates to processes for the preparation of the compounds of invention, pharmaceutical compositions containing the compounds, and their use.

    摘要翻译: 本发明涉及式I的取代苯甲酰胺衍生物及其药学上可接受的盐,药学上可接受的溶剂合物,对映异构体,非对映异构体,前药,代谢物和多晶型物,并且可用于治疗由葡萄糖激酶介导的疾病状态。 本文公开的化合物可用于降低血糖水平和用于增加用于治疗II型糖尿病的胰岛素分泌。 本发明还涉及制备本发明化合物的方法,含有这些化合物的药物组合物及其用途。

    Disubstituted benzamide derivatives as glucokinase (GK) activators
    2.
    发明授权
    Disubstituted benzamide derivatives as glucokinase (GK) activators 失效
    二取代苯甲酰胺衍生物作为葡萄糖激酶(GK)激活剂

    公开(公告)号:US08450494B2

    公开(公告)日:2013-05-28

    申请号:US13378984

    申请日:2010-06-21

    申请人: Rajendra Kharul

    发明人: Rajendra Kharul

    摘要: The invention relates to disubstituted benzamide derivatives of the general Formula (I), their pharmaceutically acceptable salts, pharmaceutically acceptable solvates, enantiomers, diastereomers, prodrugs, metabolites and polymorphs. The invention also relates to processes for the preparation of the compounds of the invention, pharmaceutical compositions containing the compounds and to methods for treating type II diabetes using the compounds of the invention.

    摘要翻译: 本发明涉及通式(I)的二取代苯甲酰胺衍生物,其药学上可接受的盐,药学上可接受的溶剂合物,对映异构体,非对映异构体,前药,代谢物和多晶型物。 本发明还涉及制备本发明化合物的方法,含有这些化合物的药物组合物和使用本发明化合物治疗II型糖尿病的方法。

    SUBSTITUTED BENZAMIDE DERIVATIVES AS GLUCOKINASE (GK) ACTIVATORS
    3.
    发明申请
    SUBSTITUTED BENZAMIDE DERIVATIVES AS GLUCOKINASE (GK) ACTIVATORS 有权
    作为GLUCOKINASE(GK)激活剂的替代苯甲酸衍生物

    公开(公告)号:US20120184544A1

    公开(公告)日:2012-07-19

    申请号:US13387885

    申请日:2010-07-22

    摘要: The present invention relates to substituted benzamide derivatives of the general Formula I and their pharmaceutically acceptable salts, pharmaceutically acceptable solvates, enantiomers, diastereomers, prodrugs, metabolites, and polymorphs and can be useful for treating disease states mediated by glucokinase. Compounds disclosed herein can be used for reducing blood glucose levels and for increasing insulin secretion for treating type II diabetes. The invention also relates to processes for the preparation of the compounds of invention, pharmaceutical compositions containing the compounds, and their use.

    摘要翻译: 本发明涉及通式I的取代苯甲酰胺衍生物及其药学上可接受的盐,药学上可接受的溶剂合物,对映异构体,非对映异构体,前药,代谢物和多晶型物,并且可用于治疗葡萄糖激酶介导的疾病状态。 本文公开的化合物可用于降低血糖水平和用于增加用于治疗II型糖尿病的胰岛素分泌。 本发明还涉及制备本发明化合物的方法,含有这些化合物的药物组合物及其用途。

    DISUBSTITUTED BENZAMIDE DERIVATIVES AS GLUCOKINASE (GK) ACTIVATORS
    4.
    发明申请
    DISUBSTITUTED BENZAMIDE DERIVATIVES AS GLUCOKINASE (GK) ACTIVATORS 失效
    作为GLUCOKINASE(GK)激活剂的分离的苯甲酸衍生物

    公开(公告)号:US20120149704A1

    公开(公告)日:2012-06-14

    申请号:US13378984

    申请日:2010-06-21

    申请人: Rajendra Kharul

    发明人: Rajendra Kharul

    摘要: The invention relates to disubstituted benzamide derivatives of the general Formula (I), their pharmaceutically acceptable salts, pharmaceutically acceptable solvates, enantiomers, diastereomers, prodrugs, metabolites and polymorphs. The invention also relates to processes for the preparation of the compounds of the invention, pharmaceutical compositions containing the compounds and to methods for treating type II diabetes using the compounds of the invention.

    摘要翻译: 本发明涉及通式(I)的二取代苯甲酰胺衍生物,其药学上可接受的盐,药学上可接受的溶剂合物,对映异构体,非对映异构体,前药,代谢物和多晶型物。 本发明还涉及制备本发明化合物的方法,含有这些化合物的药物组合物和使用本发明化合物治疗II型糖尿病的方法。